Specialized secretion systems of pathogenic bacteria commonly transport multiple effectors that act in concert to control and exploit the host cell as a replication-permissive niche. Both the Mycobacterium marinum and the Mycobacterium tuberculosis genomes contain an extended region of difference 1 (extRD1) locus that encodes one such pathway, the early secretory antigenic target 6 (ESAT-6) system 1 (ESX-1) secretion apparatus. ESX-1 is required for virulence and for secretion of the proteins ESAT-6, culture filtrate protein 10 (CFP-10), and EspA. Here, we show that both Rv3881c and its M. marinum homolog, Mh3881c, are secreted proteins, and disruption of RD1 in either organism blocks secretion. We have renamed the Rv3881c/Mh3881c gene espB for ESX-1 substrate protein B. Secretion of M. marinum EspB (EspBM) requires both the Mh3879c and Mh3871 genes within RD1, while CFP-10 secretion is not affected by disruption of Mh3879c. In contrast, disruption of Mh3866 or Mh3867 within the extRD1 locus prevents CFP-10 secretion without effect on EspBM. Mutants that fail to secrete only EspBM or only CFP-10 are less attenuated in macrophages than mutants failing to secrete both substrates. EspBM physically interacts with Mh3879c; the M. tuberculosis homolog, EspBT, physically interacts with Rv3879c; and mutants of EspBM that fail to bind Mh3879c fail to be secreted. We also found interaction between Rv3879c and Rv3871, a component of the ESX-1 machine, suggesting a mechanism for the secretion of EspB. The results establish EspB as a substrate of ESX-1 that is required for virulence and growth in macrophages and suggests that the contribution of ESX-1 to virulence may arise from the secretion of multiple independent substrates.
A major mechanism used by pathogenic bacteria for disabling host defenses is secretion of virulence proteins. These effectors are often transported by specialized secretion machines. One such pathway, present in Mycobacterium and other Gram-positive genera, is ESX-1 (early secretory antigenic target 6 system 1). Although ESX-1 is required for multiple phenotypes related to the pathogenesis of infection, only three substrates of the secretion machine have been identified to date, and the mechanism by which these substrates are exported is not understood. In our efforts to understand this virulence-related secretion mechanism, we identified a novel substrate and found that its delivery to the ESX-1 machine requires different protein interactions than previously identified substrates. Finally, we present data that the various ESX-1 substrates contribute additively to virulence. These data are incorporated into a model of ESX-1 function.
Citation: McLaughlin B, Chon JS, MacGurn JA, Carlsson F, Cheng TL, Cox JS, et al. (2007) A Mycobacterium ESX-1–Secreted Virulence Factor with Unique Requirements for Export. PLoS Pathog 3(8): e105. https://doi.org/10.1371/journal.ppat.0030105
Editor: Lalita Ramakrishnan, University of Washington, United States of America
Received: February 13, 2007; Accepted: June 11, 2007; Published: August 3, 2007
Copyright: © 2007 McLaughlin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant RO1AI055614 from the National Institutes of Health. BM was supported by the UCSF Genetics and Cell Biology Training Grant T32GM07810 and the UCSF Microbial Pathogenesis Training Grant T32AI060537 from the National Institutes of Health.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: BMDM, bone marrow–derived macrophage; CFP-10, culture filtrate protein 10; EspB, ESX-1 substrate protein B; ESAT-6, early secretory antigenic target 6; ESX-1, ESAT-6 system 1; extRD1, extended region of difference 1; FAP, fibronectin attachment protein; OD, optical density; RD1, region of difference 1
The cell surface–associated and secreted proteins of pathogenic bacteria promote the uptake of nutrients; facilitate attachment to specific surfaces, cells, or proteins; function in cell wall maintenance and cell division; and offer protection from harsh environmental conditions, including the host immune system. In Mycobacteria, there are at least four pathways to secrete proteins—Sec, SecA2, twin-arginine translocase, and the early secretory antigenic target 6 (ESAT-6) system 1 (ESX-1). Much attention has been focused on the ESX-1 pathway because it is required for virulence and for the secretion of ESAT-6 and culture filtrate protein 10 (CFP-10), two major targets of the immune response in infected individuals.
M. tuberculosis ESX-1 is required for virulence in mice, growth in macrophages, and the suppression of macrophage inflammatory and immune responses, including the arrest of phagosome maturation and the reduced expression of IL-12 and TNF-α [1–6]. The homologous M. marinum ESX-1 is required for virulence in zebrafish, growth in macrophages, cytolysis and cytoxicity, and cell-to-cell spread, in addition to ESAT-6 and CFP-10 secretion [7,8]. In zebrafish embryo infections, M. marinum ESX-1 is required for macrophage aggregation and granuloma formation . In M. smegmatis, ESX-1, in addition to being required for secretion of ESAT-6 and CFP-10, modulates conjugal DNA transfer [10,11]. In contrast, most strains of M. ulcerans, which is closely related genetically to M. marinum and M. tuberculosis, but persists in extracellular locations during mammalian infection, lack most of the ESX-1 components as well as orthologs of the genes extending from Rv3879c thru Rv3883c [12,13]. Although the ESX-1 secretion machinery (Rv3870, Rv3871, and Rv3877) is required for the arrest of phagosome maturation by M. tuberculosis during an infection of macrophages, the known ESX-1 substrates are dispensable . The multiple phenotypes and host responses dictated by the ESX-1 secretory apparatus suggest that there may be additional substrates, components, and regulatory molecules yet to be identified.
Recently, a third ESX-1 substrate, EspA (Rv3616c), was identified . Unlike ESAT-6 and CFP-10, EspA is encoded at a locus distant from the ESX-1 machine, yet this substrate is codependent with both ESAT-6 and CFP-10 for secretion. The mechanism for this interdependence has not been determined, but the interaction between ESAT-6 and CFP-10 in the bacterial cytosol appears to be required for secretion of the heterodimer [15–18]. Presumably, the stable heterodimer is also required for the secretion of EspA.
The M. tuberculosis region of difference 1 (RD1) locus (Rv3871-Rv3879c) and the neighboring genes encode the ESX-1 substrates ESAT-6 and CFP-10, as well as core components of the secretion machine [1–3]. These core components include at least two putative SpoIIIE/FtsK ATPase family members (Rv3870 and Rv3871), a proline-rich predicted chromosome-partitioning ATPase (Rv3876), and a putative transporter protein with 12 transmembrane domains (Rv3877). The non-RD1 gene cluster Rv3616c-Rv3614c also is required for secretion of the known substrates [14,19]. Additional proteins are likely to be necessary for the assembly of the ESX-1 machinery, because in M. smegmatis, genes extending from homologs of Rv3866 through Rv3883c have been shown to be required for ESX-1–mediated secretion ; an M. bovis mutant disrupted for the expression of the genes homologous to Rv3867 through Rv3869 fails to secrete ESAT-6 and CFP-10 ; and in M. marinum, the locus required for ESX-1–mediated secretion extends at least from the homolog of Rv3866 (Mh3866) to the homolog of Rv3881c (Mh3881c), which in this work we rename espB (see below) .
Although these studies have identified multiple genes required for ESX-1 function, the biochemical interactions necessary for assembly of the secretion machine and for transport of substrates are still not understood. A model for CFP-10 secretion is that the carboxyterminus of the CFP-10 substrate is recognized by Rv3871, which in turn interacts with the integral membrane protein Rv3870 to direct CFP-10 through the secretion pore . The interaction of CFP-10 with Rv3871 is also required for secretion of ESAT-6, suggesting that this is a requisite step in secretion of the ESAT-6/CFP-10 heterodimer by the ESX-1 machine.
Here, we show that Rv3881c and its M. marinum homolog, Mh3881c, are substrates for secretion by ESX-1. For this reason, we have named the gene product of this locus ESX-1 substrate protein B (EspB). In both species, espB encodes a gylcine-rich protein with a predicted molecular weight of ∼47 kDa, without any region of apparent similarity to the secretion signal of CFP-10 or other known secretion signals. Although a substrate of ESX-1, we find that the specific genes required for secretion of EspB differ from those required for the secretion of CFP-10. Biochemical investigation demonstrates that EspB forms a complex with Rv3879c and that Rv3879c interacts with Rv3871, the same component of ESX-1 that interacts with the ESAT-6/CFP-10 complex during its secretion. These data support a model that different substrates are delivered to the ESX-1 machine by molecularly distinguishable pathways. Moreover, each of these pathways for ESX-1–mediated secretion contributes to mycobacterial virulence.
Both M. tuberculosis and M. marinum EspB Restore Intracellular Growth to the M. marinum Mutant espBM::tn
A previous genetic screen for M. marinum mutants that fail to cause hemolysis led to the isolation of eight mutants in the extended RD1 (extRD1) locus, Mh3866-Mh3881c . Of the eight mutants, espBM::tn (Mh3881c::tn) was the most attenuated for virulence to zebrafish, growth in macrophages, and cytotoxicity to J774 cells. Thus, we decided to investigate the espBM–encoded protein (EspBM) and its M. tuberculosis homolog (EspBT) in detail. The gene, espBM, is the first in a two-gene operon. Using quantitative RT-PCR, we found that the mutation disrupts the expression of both genes in the operon (unpublished data). We then sought to determine the genetic requirements for restoration of intracellular growth to the mutant. Introduction of a non-integrating plasmid, expressing either EspBM from the espBM promoter or EspBT from its native promoter, was sufficient to appreciably restore growth in macrophages to espBM::tn (Figure 1A). The non-integrating plasmids expressing both EspBM and Mh3880c or both EspBT and Rv3880c were not superior in restoration of intracellular growth. Thus, EspB is necessary and sufficient to appreciably complement espBM::tn, and the M. tuberculosis homolog functions equally well in M. marinum, demonstrating conservation of function.
BMDMs were infected at a multiplicity of infection of 1. Colony-forming units (cfu) were determined by lysing infected monolayers and plating lysates at indicated time points. Data were combined for three experiments, with growth indicated as fold increase compared to the initial level of infection for each strain.
(A) Wild type (Wt) and espBM::tn each contain the empty non-integrating plasmid pLYG206; p(espBM) and p(espBT) are plasmids for expression of EspBM and EspBT, respectively; and p(espBM-Mh3880c) and p(espBT-Rv3880c) encode the second gene of the operon as well as espB for each species.
(B) Wild type (Wt) and espBM::tn each were transformed with the empty integrating plasmid and the indicated genes were integrated into the attB of the espBM::tn mutant. espBM::tn + p(Mh3883c-Mh3880c) expresses the locus Mh3883-Mh3880c on a non-integrating plasmid. Strains differed significantly by one-way ANOVA in (A) after 24 h, 48 h, 72 h, and 96 h and in (B) after 16 h, 43 h, 75 h, and 92 h (p < 0.001 for each).
While the expression of EspBM from a non-integrating plasmid appreciably restored growth in macrophages to espBM::tn, the complementation was not complete. Among possible explanations are that the transposon insertion exerted a polar effect on the operon upstream, Rv3883c-Rv3882c, which also might have a role in intracellular growth, or that a proper stoichiometry between EspB and ESX-1 is required for complete complementation. Therefore, integrating plasmids encoding either espBM along with the espBM promoter, espBM-Mh3880c along with the espBM promoter, or the entire locus Mh3883c-Mh3880c along with the Mh3883c promoter, were introduced into espBM::tn. The locus Mh3883c-Mh3880c, along with the Mh3883c promoter, was also introduced into espBM::tn on a non-integrating plasmid. Of these constructs, only the integrating plasmids encoding espBM-Mh3880c or Mh3883c-Mh3880c fully complemented the growth defect of espBM::tn (Figure 1B). Similarly, espBM alone appreciably restored a rough colony morphology to the espBM::tn mutant, but espBM-Mh3880c or Mh3883c-Mh3880c fully restored the rough colony morphology to espBM::tn (Figure S1). These results suggest that Mh3880c can contribute to M. marinum growth in macrophages when it is expressed along with espBM from the bacterial chromosome. In contrast, espBM contributes equally well to bacterial virulence whether expressed episomally or on the chromosome, suggesting that its contribution is more independent of its stoichiometry with respect to other virulence components.
EspB Is a Secreted Protein That Undergoes Carboxyterminal Processing
As a first step toward understanding the role of EspB in virulence and growth in macrophages, we determined its localization in Mycobacteria grown in broth culture. The cell lysate and culture filtrate fractions of M. tuberculosis H37Rv, wild-type M. marinum, and M. marinum espBM::tn were probed with a mouse polyclonal antibody raised against a 100 amino acid fragment of EspBT extending from amino acid 234 to 333 (Figure 2A). EspB was detected in both the cell lysate and the culture filtrate fractions of M. tuberculosis, as well as in both the cell lysate and the culture filtrate fractions of wild-type M. marinum. EspB was not detected in either fraction of the espBM::tn culture, verifying the specificity of the antibody. GroEL, a non-secreted bacterial cytoplasmic protein, was found exclusively in the cell lysate, demonstrating that EspB did not appear in the culture filtrate as a result of cell lysis.
Cell lysates (CL) and culture filtrates (CF) were prepared from the indicated strains as described in Materials and Methods. Proteins were separated by SDS-PAGE, and the indicated proteins were detected by western blot as described in Materials and Methods.
(A) 60 μg of total CL and 30 μg of total CF of M. tuberculosis Erdman and each of the M. marinum strains were loaded in each well.
(B) 60 μg of total CL and 30 μg of total CF were loaded in each well.
(C) Cultures of each strain were grown in 7H9 to an OD of 0.5 and then inoculated into Sauton's medium at an OD of 0.5 and grown for 36 h. Therefore, the samples of each strain are normalized by OD readings. Of the total CL and CF fractions collected for each strain from one experiment, 3% of the CL was loaded in each lane and 15% of the total CF was loaded into each lane. The results shown are representative of the results obtained in four replications of this experiment.
(D) 30 μg of total CL and 30 μg of total CF of each M. tuberculosis Erdman strain were loaded in each well.
The EspB in the cell lysate had an Mr of 55 kDa on SDS-PAGE, while the EspB in the culture filtrate of both species ran at a slightly lower molecular weight. A lower molecular weight of EspB in the culture filtrate was also observed in a prior proteomic analysis of M. tuberculosis H37Rv proteins , in which EspB in the cell lysate was observed on a 2-D gel as a single spot with an apparent molecular weight of 55.6 kDa, while the EspB in the culture filtrate was observed as two spots with apparent molecular weights of 49.7 kDa and 48.4 kDa. Therefore, EspB might be cleaved either during or after secretion. To test this possibility, a V5 epitope tag was fused to the N-terminus of EspBM and a His6x epitope tag was fused to the C-terminus. The resulting construct, V5-EspBM-His6x, was expressed in the espBM::tn mutant. Like the native protein, V5-tagged EspB was detected in the cell lysate as a single band and as a doublet in the culture filtrate (Figure 2B). In contrast, His-tagged protein was only detected in the cell lysate fraction, suggesting that EspBM in the culture filtrate is C-terminally truncated.
EspB Secretion Requires a Distinct Set of extRD1-Encoded Genes for Secretion
To assess which ESX-1 genes are required for EspB secretion, its compartmentalization between cell lysate and culture filtrate was determined for several M. marinum ESX-1 mutants (Figure 2C). Although EspBM was found in both the cell lysate and culture filtrate fractions of most mutants, EspBM was not detected in the culture filtrates of MmΔRD1, Mh3868::tn, Mh3879c::tn, or Mh3871::tn.
The Mh3868::tn mutants failed to accumulate protein in the pellet, suggesting that Mh3868 protein could be involved in EspB synthesis or stability. Thus, of the ESX-1 genes tested, only Mh3879 and Mh3871 were clearly involved in EspBM secretion. In contrast, none of the mutants secreted ESAT-6 , and only Mh3879c::tn and Mh3878c::tn secreted CFP-10 normally. This difference in secretion requirements for ESAT-6 and CFP-10 in M. marinum has been noted previously . Complementation of Mh3879::tn and espB::tn restored EspBM secretion. GroEL was absent from culture filtrates of all strains, and secretion of the fibronectin attachment protein (FAP), a protein secreted in a Sec-dependent manner , was not disturbed in any of the extRD1 mutants. Thus, the product of the espBM gene is a secreted protein that requires Mh3871, a core component of the ESX-1 secretion machine, for export; we have therefore named it ESX-1 substrate protein B (EspB). However, EspB, ESAT-6, and CFP-10 differ with respect to the extRD1 genes required for their secretion. EspBM secretion depends on Mh3879c, but is independent of Mh3866 and Mh3867, while CFP-10 shows the inverse pattern.
To demonstrate the importance of the ESX-1 machine in EspB secretion in another strain of M. marinum, we examined the 1218R strain and an isogenic mutant in which the Mh3871 gene had been disrupted. The M strain, used for the previous experiments, is a human isolate, whereas 1218R was originally isolated from an infected fish. Wild-type 1218R secreted EspB, but the Mh3871 mutant did not (Figure S2), confirming the importance of ESX-1 in the secretion of this protein by M. marinum. Complementation of the mutant with either the M. marinum or M. tuberculosis homolog of Mh3871 restored secretion of EspBM to this mutant, suggesting parallel functions for the genes in the two species.
To test directly whether ESX-1 was required for EspB secretion by M. tuberculosis, we examined culture filtrates from M. tuberculosis Erdman and the isogenic mutants Rv3870::tn, Rv3871::tn, and ΔCFP-10 (Figure 2D). Secretion of EspBT by wild-type M. tuberculosis was abrogated in the Rv3870 and Rv3871 mutants, but not in the ΔCFP-10 mutant. Thus, EspB is a secreted protein in both M. marinum and M. tuberculosis, and its secretion requires core ESX-1 components in both species of Mycobacteria. Importantly, EspB is the first ESX-1 substrate in M. tuberculosis whose secretion is not disrupted in the ΔCFP-10 mutant.
MmΔRD1, espBM::tn, and Mh3871::tn Are More Attenuated for Growth in Macrophages than the Other M. marinum extRD1 Mutants
Of the ten M. marinum extRD1 mutants we examined, MmΔRD1, espBM::tn, and Mh3871::tn were disrupted for the secretion of all three substrates: ESAT-6, CFP-10, and EspBM. In contrast, the Mh3879::tn mutant was disrupted only for the secretion of ESAT-6 and EspBM, while the Mh3866::tn and Mh3867::tn mutants were disrupted only for ESAT-6 and CFP-10 secretion. To assess the importance of the multiple ESX-1 substrates for growth in macrophages, we infected murine bone marrow–derived macrophages (BMDMs) with wild-type M. marinum, with strains lacking one secreted effector, or with strains lacking secretion of all the known ESX-1 substrates. As shown in Figure 3, MmΔRD1, espBM::tn, and Mh3871::tn, which fail to secrete all substrates, are more attenuated for growth in macrophages than Mh3866::tn, which still secretes EspBM, or Mh3879c::tn, which still secretes CFP-10. Therefore, we conclude that the various substrates of ESX-1 each contribute to virulence.
BMDMs were infected with M. marinum strains as described in Materials and Methods at a multiplicity of infection of 1, and growth of bacteria was monitored over time as in Figure 1. Data are summarized from three independent experiments. Strains differed significantly by one-way ANOVA after 24 h, 48 h, 72 h, 96 h, and 120 h (p < 0.001 for each).
EspB Physically Interacts with the Rv3879c
To learn more about the involvement of ESX-1 in EspB secretion, we tested whether EspB would interact with other ESX-1 genes by bacterial two-hybrid analysis (Figure 4). An advantage of the bacterial two-hybrid system is that it can allow detection of interactions of membrane-bound proteins . In this assay, potential protein–protein interactions are assessed by determining the ratio of colonies that grow on selective medium to the number grown on non-selective medium. For each of the bait plasmids, co-transformation with an empty target resulted in a ratio of colonies on selective to non-selective medium of less than 0.1%, as did co-transformation of the EspBT target with an empty bait. In contrast, the Rv3879c bait and EspBT target resulted in a ratio of 7.6%, an increase of more than 75-fold. An Rv3876 bait also showed interaction above background with EspBT, but since the M. marinum Mh3876::tn mutant showed significant EspBM secretion (Figure 2C), any interaction between Rv3876 and EspBT is not likely to be required for EspB secretion and thus was not pursued.
The target plasmid containing EspBT fused to the RNA polymerase alpha subunit was co-transformed with each of the bait plasmids containing the indicated extRD1 proteins fused to the lambda repressor into the reporter validation strain. Shown is the ratio of growth of the co-transformants on selective (+5 mM 3AT) versus non-selective plates. The experiment depicted is representative of three independent determinations.
To test for an analogous interaction between EspBM and Mh3879c and to confirm the potential interaction between EspBT and Rv3879c suggested by the two-hybrid assay, we performed in vitro pull-down assays. All of the proteins used were expressed in Escherichia coli as GST- or V5-epitope-tagged fusions. Controls for nonspecific interactions included GST alone, as well as GST-syntaxin2, and GST-Shp1. As shown in Figure 5A, GST-tagged EspBM, but none of the GST controls, bound specifically to V5-tagged Mh3879c. In the reciprocal experiment, GST-tagged Mh3879c bound specifically to V5-EspBM. Similarly, as shown in Figure 5B, GST-tagged EspBT bound specifically to V5-tagged Rv3879c, and GST-tagged Rv3879c bound specifically to V5-tagged EspBT. These data demonstrate that recombinant EspBT and Rv3879c, as well as their M. marinum homologs, interact in vitro.
(A) Agarose beads with immobilized GST, GST-SHP1, GST-syntaxin2, GST-Mh3879c, and GST-EspBM were incubated with lysates of E. coli that express V5-Mh3879c and V5-EspBM.
(B) Agarose beads with immobilized GST, GST-SHP1, GST-syntaxin2, GST-Rv3879c, or GST-EspBT were incubated with lysates of E. coli that express V5-Rv3871, V5-Rv3879c, and V5-EspBT. Proteins from cell lysates retained on the beads after washing were separated by SDS-PAGE and detected by western blotting with an antibody against V5. To the right of each set of pulldowns, 0.1% of the input E. coli lysate was analyzed. EspBM physically interacts with Mh3879c, EspBT physically interacts with Rv3879c, and Rv3879c also interacts with Rv3871.
Since Rv3871 mutants in both M. tuberculosis and M. marinum fail to secrete EspB, we used GST pulldowns to test whether Rv3871 interacts with either EspBT or Rv3879c. GST-tagged Rv3879c bound to V5-tagged Rv3871, whereas the GST controls and GST-EspBT did not bind to Rv3871. This suggests that Rv3879c may facilitate EspBT secretion through an interaction with Rv3871.
The Carboxyterminus of EspB Is Dispensable for Interaction with Mh3879c and for Secretion
To identify whether EspB, like CFP-10, requires its carboxyterminus for secretion, we constructed a series of EspBM deletion mutants with N-terminal V5 tags and expressed them in the espBM::tn mutant strain using the espBM promoter. As shown in Figure 6A, V5-tagged full-length EspBM was secreted. This N-terminally tagged protein, like native EspBM, underwent C-terminal truncation either during or after secretion. EspBM deletion mutant constructs Δ(2–31), Δ(264–271), and Δ(400–454) were stably expressed in M. marinum, but only EspBM Δ(400–454) accumulated in the culture filtrate. The secreted EspBM Δ(400–454) had a higher apparent molecular weight than the secreted full-length EspBM, presumably because deletion of the C-terminal 55 amino acids inhibits some of the carboxyterminal proteolytic processing. This result demonstrates that the C-terminus of EspBM is dispensable for secretion, but N-terminal and internal amino acids are required. Next, we tested how these EspBM mutants interacted with Mh3879c. Lysates of E. coli that express V5-tagged EspBM mutants were incubated with GST-Mh3879c. While full-length EspBM and EspBM Δ(400–454) bound to GST-Mh3879c, the stably expressed but non-secreted EspBM Δ(2–31) and EspBM Δ(264–271) constructs did not bind to GST-Mh3879c (Figure 6B). These data support a model in which EspB interacts with Rv3879c, which in turn interacts with Rv3871, to facilitate the secretion of EspB.
(A) The M. marinum espBM::tn mutant was transformed with a non-integrating plasmid expressing N-terminally V5-tagged EspBM full length, EspBM Δ(2–31), EspBM Δ(264–271), or EspBM Δ(400–454). Cell lysates (CL) and culture filtrates (CF) were prepared from the indicated strains as described in Materials and Methods. The samples of each strain are normalized by OD readings. Of the total CL and CF fractions collected for each strain from one experiment, 3% of the CL was loaded in each lane and 15% of the total CF was loaded into each lane, separated by SDS-PAGE and detected by western blotting with an antibody against V5.
(B) Agarose beads with immobilized GST-Mh3879c were incubated with E. coli lysates expressing V5-tagged EspBM full length, EspBM Δ(2–31), EspBM Δ(264–271), or EspBM Δ(400–454). The input lysate (0.1%) and the material from the cell lysates that bound to the beads was run on SDS-PAGE and detected by western blotting with an antibody against V5.
Mh3879c Is Not Secreted
Because CFP-10 and ESAT-6 are secreted as a heterodimer, we assessed whether Mh3879c and EspB might be secreted similarly. The fusion constructs V5-Mh3879c, Mh3879c-His6x, and V5-Mh3879c-His6x were expressed from the endogenous Mh3879c promoter on non-integrating plasmids in both wild-type M. marinum and in the Mh3879c::tn mutant. Introduction of V5-Mh3879c fully complemented the EspBM secretion defect of the Mh3879c::tn mutant, but Mh3879c-His6x and V5-Mh3879c-His6x failed to complement the secretion defect (Figure S3A). In wild-type M. marinum, V5-Mh3879c and V5-EspBM were expressed at nearly identical levels in the cell lysate, but only V5-EspBM was detected in the culture filtrate (Figure S3A). To determine whether failure of secretion reflected inefficient competition of V5-tagged protein with native protein, the V5-EspBM secretion was also analyzed in the Mh3879::tn mutant. In this strain as well, V5-Mh3879c was found only in the cell lysate. Thus, V5-tagged Mh3879c, while fully competent to mediate EspB secretion, was not itself secreted, suggesting that Mh3879c and EspB are not secreted as a heterodimer. The C-terminally His6x-tagged Mh3879c, which did not restore EspB secretion to the Mh3879::tn mutant, also was detected only in the cell lysate. Since Mh3879c-His6x failed to complement the EspBM secretion defect of the Mh3879c::tn mutant, we hypothesized that the carboxyterminus of Rv3879c might be required for interaction with EspB. To test this hypothesis, lysates of E. coli that express V5-tagged Rv3879 mutants were incubated with GST alone, GST-Rv3871, or GST-EspBT. While full-length Rv3879 and Rv3879 Δ(1–166) bound to GST-EspBT, Rv3879 Δ(564–729) failed to bind to GST-EspBT (Figure S3B). None of the constructs bound to GST alone, and all three constructs bound to GST-Rv3871. Thus, the carboxyterminal 166 amino acids of Rv3879 are required for EspB secretion, but not for interaction with the ESX-1 machine.
In this study, we identified EspB as a novel substrate of the ESX-1 secretion system and demonstrated a requirement for the Mh3879c and Mh3871 genes in the secretion of EspBM. Further, we showed protein complex formation between EspBM and Mh3879c, as well as identical behavior of their M. tuberculosis homologs. Two mutants of EspBM that were stable after synthesis but failed to bind Mh3879c were not secreted, while a large carboxylterminal deletion did not interfere with either Mh3879c binding or secretion. Additionally, the carboxyterminus of Rv3879c/Mh3879c is required for interaction with and secretion of EspB. These results suggest that the EspB/Mh3879c protein complex is required for EspBM secretion. While complex formation between ESAT-6 and CFP-10 is required for their secretion as a heterodimer by M. tuberculosis, Mh3879c appears not to be secreted. Our data, though, do not exclude the possibility that the aminoterminus of Mh3879c is quantitatively removed during or immediately after secretion, since we do not have and could not probe with antibodies to the native protein. We hypothesize that Mh3879c acts as a cytosolic chaperone to deliver EspBM to the secretion machine. We showed that Rv3879c interacts directly with Rv3871 and that Rv3871, in addition to being required for the secretion of ESAT-6/CFP-10, is required for the secretion of EspB. Although our work does not reveal precisely how EspB is delivered to the ESX-1 machine, our data demonstrate that Rv3879c can interact with Rv3871 as well as with EspBT, suggesting that EspB may be targeted to Rv3871 in this way. We propose that the mechanisms of EspB and CFP-10 secretion intersect at binding to Rv3871 (Figure 7).
Depicted are the core ESX-1 components Rv3870, Rv3871, and Rv3877, as well as the ESAT-6/CFP-10 and EspB/Rv3879c complexes. Both cytosolic complexes require interaction with Rv3871 for substrate secretion.
We also found that disruption of Mh3868 leads to loss of accumulation of EspB in the bacterial cytosol. We previously observed that disruption of Mh3868 prevents bacterial accumulation of ESAT-6 and CFP-10 . Mh3868 and its M. tuberculosis homolog Rv3868 are predicted to be AAA ATPases, which suggests that they may function as chaperones for the translocation of ESX-1 substrates, but little is known about this key protein. We have found that CFP-10 and espBM mRNAs are expressed in the Mh3868::tn mutants (B. McLaughlin and E. Brown, unpublished data), suggesting that the Mh3868 gene product affects either the translation or stability of the ESX-1 substrates. Characterizing the function of Mh3868 will certainly be important to better understand ESX-1–mediated secretion.
Like ESAT-6 and CFP-10, EspA is secreted by the ESX-1 machine. Whether any of the M. marinum genes with sequence similarity to espA are functional orthologs has not yet been determined. Loss of either EspA or EspB inhibits secretion of ESAT-6 and CFP-10, but the reason for their requirement is unknown. It may be that as substrates reach the final common pathway for secretion, they interact in a manner that leads to cooperative secretion. Clearly, though, the secretion of EspB is quite distinct from that of EspA. While EspA requires CFP-10 for its secretion, EspB secretion is independent of CFP-10. EspB secretion is not disrupted in the M. marinum mutants Mh3866::tn and Mh3867::tn, neither of which secrete CFP-10, nor is EspB secretion disrupted in the M. tuberculosis ΔCFP-10 mutant. These data are consistent with the model that EspB, unlike either ESAT-6 or EspA, is targeted to the ESX-1 machine independently of CFP-10.
These studies beg the question of whether it is possible to determine which ESX-1 substrates are most important for virulence. This has been a difficult task because of the apparent codependence of the various substrates on each other for secretion. However, our results allowed a somewhat different approach. We used a set of extRD1 mutants in which some (Mh3866::tn and Mh3867::tn) failed to secrete CFP-10, but did secrete EspB; while another mutant (Mh3879::tn) secreted CFP-10 but failed to secrete EspB; while mutants that disrupted the core secretion machinery (MmΔRD1 and Mh3871::tn) and espBM::tn itself failed to secrete all substrates. We found that mutants lacking secretion of both substrates had a more marked growth defect in macrophages than the mutants lacking secretion of only one substrate. This suggests that the different substrates make distinct, and potentially additive, contributions to virulence. Although we cannot say that the defects in intracellular growth of the various mutants are caused by the substrates we have identified, our work does support the hypothesis that ESX-1 secretes more than one substrate that contributes to the virulence of Mycobacteria and that different substrates may have independent contributions to bacterial pathogenesis.
In summary, this work has identified a novel substrate for ESX-1–dependent secretion and has demonstrated interactions of this substrate with a protein encoded within RD1, expanding our understanding of how genes within this locus contribute to this novel secretion pathway. Furthermore, we have demonstrated that secretion of distinct ESX-1 substrates follows variable pathways to interaction with the core secretion machinery, and that the different substrates may contribute independently to intracellular survival and growth of the bacteria. These data extend the understanding of a major virulence mechanism of Mycobacteria.
Materials and Methods
Bacterial strains and plasmids.
All strains and plasmids used in this study are listed in Table 1. M. marinum strains were grown as previously described . The designations assigned by the Sanger Institute in the annotation of the M. marinum genome and the corresponding DNA sequences are available at http://www.sanger.ac.uk/Projects/M_marinum/.
List of Bacterial Strains and Plasmids Used in This Study
The transposon insertion in the mutant espBM::tn lies between the 175th and 176th base pairs of the espBM gene, and the kanamycin gene within the transposon is transcribed opposite to the direction of transcription of the espBM gene. The strains M. marinum M attB::hygr and espBM::tn attB::hygr were constructed by transforming the strains M. marinum M WT and espBM::tn with the plasmid pMV306.hyg. The strains espBM::tn attB:: espBM hygr and espBM::tn attB:: espBM -Mh3880c hygr were constructed by ligating 250 bp upstream of espBM along with espBM or espBM -Mh3880c into pMV306.hyg and then transforming the resulting plasmids, pBM264 and pBM262, into espBM::tn. The strain espBM::tn attB:: Mh3883c-Mh3880c hygr was constructed by ligating 345 bp upstream of Mh3883c along with Mh3883c-Mh3880c into pMV306.hyg and then transforming the resulting plasmid, pBM263, into espBM::tn. To construct the plasmids pBM841, pBM540, and pBM810, the genes Rv3871, Rv3879c, and Rv3881c were PCR amplified from the cosmid RD1-2F9  and ligated into pBM510, a derivative of pET22b+ in which the N-terminal His tag was replaced with the V5 epitope tag. To construct the plasmids pBM843 and pBM504, the genes Mh3879c and Mh3881c were PCR amplified from M. marinum M genomic DNA and ligated into pBM510. To construct the plasmids pBM332 and pBM336, a series of fragments were ligated into pLYG206 to achieve the following sequence ligated into the NotI and XbaI sites: 250 bp upstream of espBM, then the V5 epitope, then the espBM gene, and finally, in the case of the pBM336 plasmid, the His6x epitope. The plasmids pBM869, pBM870, and pBM871 were made in a manner synonymous to that of pBM332 and pBM336, where the Mh3879 promoter and gene were used. The plasmids pBM367 and pBM400v were constructed by PCR from pBM332 and re-ligation of the truncated gene fragments back into pBM332, while pBM398 was generated by quick-change mutagenesis (Stratagene, http://www.stratagene.com/). For pBM589, pBM398e, and pBM400ve, the espBM gene fragments in the plasmids pBM367, pBM398, and pBM400v were cut by restriction digest and ligated into pBM504. For pBM856, pBM550, pBM553, and pBM551, the genes Mh3879c, espBM, Rv3879c, and espBT were cut by restriction digest from the plasmids pBM843, pBM504, pBM540, and pBM810 and ligated into the GST expression vector pGex-KG. To construct the plasmid pMh3879, 250 bp upstream of the gene Mh3879c together with Mh3879c was PCR amplified from M. marinum genomic DNA and inserted into pLYG206. The plasmids pBM1010 and pBM1013 were constructed by restriction digests of pBM540 to excise portions of Rv3879c, and ligation of 5′ phosphorylated hybridized oligos that restored the frame and created the Rv3879 deletions Δ(1–166) and Δ(564–729). To construct the plasmid p(Mh3883c-Mh3880c), the 345 bp upstream of Mh3883c along with Mh3883c-Mh3880c was cut by restriction digest from the plasmid pBM263 and inserted into pLYG206. To construct the plasmid p(espBT-Rv3880c), 250 bp upstream of the operon Rv3881c-Rv3880c together with the operon were inserted into pLYG206.
Protein preparation and analysis.
M. marinum strains were grown in 40-mL cultures to 0.5 OD600 in 7H9 medium. The cultures were centrifuged and washed three times with 15 mL of PBS before re-suspension in 40 mL of Sauton's medium, supplemented with 0.015% Tween-80. When strains containing non-integrating plasmids for complementation were grown in Sauton's medium, the Sauton's medium was supplemented with Zeocin (5 μg/ml; Invitrogen, http://www.invitrogen.com/). After growth for 36 h at 30 °C, 105 rpm, in Sauton's medium, the cells were harvested by centrifugation. Supernatants were filtered through a 0.22-μm-pore-size filter with a glass pre-filter and concentrated with an Amicon Ultra-15 (5,000-molecular-weight cutoff; Millipore, http://www.millipore.com/) to 200 μL, which was saved as the culture filtrate (CF) fraction.
Pelleted cells were washed and resuspended in 1.5 mL of PBS with a protease inhibitor cocktail and 1 mM PMSF. Pellets were lysed using glass beads and the mini-bead beater (BioSpec Products, http://www.biospec.com/) with three 40-s pulses at maximum speed and incubations on ice in between each pulse, and then centrifuged at 3,000g for 2 min at 4 °C to remove unbroken cells. The resulting supernatant was collected and saved as the cell lysate (CL) fraction. M. tuberculosis (Erdman) culture filtrate and cell lysate fractions were prepared as previously described . Total protein concentrations were determined by a Bradford assay.
Western immunoblot assay.
Pellet and culture filtrate fractions were separated by SDS/PAGE on 10%–20% gradient polyacrylamide gels for detection of CFP-10; 7.5% polyacrylamide gels for detection of EspB, GroEL, or V5-tagged Mh3879; and 12.5% polyacrylamide gels for detection of FAP. Proteins were visualized by immunoblotting by using antibodies against EspB at a concentration of 1:500 (mouse polyclonal to the 100 amino acid fragment of Rv3881c [234–333 aa], Arizona State University CIM Antibody Core), and the blot was developed using ECL reagent West Dura (Pierce, http://www.piercenet.com/). Anti-CFP-10 (rabbit polyclonal; Colorado State University, http://www.cvmbs.colostate.edu/microbiology/tb/top.htm) was used at a concentration of 1:50000, blots of the culture filtrate fraction were developed using West Pico (Pierce), and blots of the cell lysates were developed using West Dura (Pierce). Anti-GroEL (rabbit polyclonal, SPA-875 / SPS-875; Stressgen, http://www.assaydesigns.com/) was used at a concentration of 1:10000, and blots were developed using West Pico (Pierce). Anti-FAP  for M. marinum samples was a rabbit polyclonal, used at a concentration of 1:10000 and developed using West Pico (Pierce). Anti-FAP for M. tuberculosis Erdman samples was CS-93 (Colorado State University), mouse monoclonal, used at a concentration of 1:20, and developed using West Pico (Pierce). His6x epitope was detected with a mouse monoclonal (Novagen, http://www.emdbiosciences.com/html/NVG/home.html) at a concentration of 1:1500, and V5 epitope was detected with a mouse monoclonal (R960–25, Invitrogen), at a concentration of 1:5000, and these blots were developed using West Pico (Pierce).
Bacterial two-hybrid system assay.
The genes Rv3614c, Rv3615c, and Rv3616c, which were PCR amplified from genomic DNA, and each of the genes in the region Rv3864 through Rv3883, which were PCR amplified from the cosmid RD1-2F9 , were cloned into the “bait” vector pBT (BacterioMatch II; Stratagene) in frame with cI. Rv3881c was cloned into the “target” vector pTRG in frame with the N-terminal subunit of RNA polymerase according to the manufacturer's instructions. The constructs were co-transformed into the E. coli two-hybrid system reporter validation strain XL1-Blue MRF′ hisB lac [F′ laqIq HIS3 aadA Kanr] and plated onto both the selective (+5 mM 3AT) and the non-selective screening medium according to the manufacturer's instructions. The non-selective screening plate is histidine-dropout M9 agar supplemented with 0.5 mM IPTG, 12.5 μg/ml tetracycline, and 25 μg/ml chloramphenicol. The selective screening plate is histidine-dropout M9 agar supplemented with 0.5 mM IPTG, 12.5 μg/ml tetracycline, 25 μg/ml chloramphenicol, and 5 mM 3-amino-1,2,4-triazole.
GST fusion proteins, GST alone, and V5-tagged proteins were expressed in the BL21-RP codon plus E. coli strain (Stratagene) by addition of 0.2 mM IPTG (3 h at 30 °C). Bacterial cultures were lysed in buffer containing 50 mM HEPES (pH 7.4), 300 mM NaCl, 1% Triton X-100, 0.5 mM EDTA, and protease inhibitor cocktail (Roche). Solubilized proteins were separated by centrifugation at 20,000g for 10 min. The GST fusion proteins and GST alone were bound to glutathione agarose beads (Amersham Biosciences, http://www.gelifesciences.com) by incubation overnight at 4 °C. The beads were then extensively washed with PBS containing 0.1% Triton X-100. Bacterial lysates containing solubilized V5-tagged proteins, in lysis buffer, were incubated with the GST protein–loaded agarose beads overnight at 4 °C. After washing three times with PBS containing 1% Triton X-100, bead-bound protein was eluted in Laemmli buffer, seperated by SDS-PAGE, and analyzed by western blot.
All macrophages used in these experiments were derived from bone marrow cells of C57BL/6 mice that were differentiated for 6 d in DMEM supplemented with 10% CMG supernatant  and 10% fetal bovine serum (FBS; HyClone, http://www.hyclone.com/). Immediately prior to infection, macrophage monolayers were washed once with FBS-free DMEM. M. marinum strains were each grown to OD600 of 1.0, prepared for infection, and incubated with macrophages as previously described . All infections were performed at a multiplicity of infection of 1, for 2 h at 32 °C, in a 5% CO2, humidified environment, in 24-well plates. The time at which M. marinum was added to the well was designated time zero. At the end of the 2 h incubation period (T = 2 h), infected monolayers were washed twice with DMEM and further incubated in DMEM containing 0.1% FBS and 200 μg of amikacin/ml for 2 h to kill extracellular bacteria. At the end of the antibiotic treatment, monolayers were washed twice with DMEM and incubated in DMEM containing 0.1% FBS at 32 °C and 5% CO2. Intracellular bacteria were enumerated by lysing macrophage monolayers and diluting and plating bacteria exactly as described . Statistical analysis was performed by calculating the one-way analysis of variance (ANOVA) with GraphPad Prism 4.0 (GraphPad Software, http://www.graphpad.com).
Figure S1. Colony Morphology of espBM::tn
Dilutions of each strain were grown on 7H10 agar, without antibiotics, and imaged after 12 d.
(5.9 MB TIF)
Figure S2. Mh3871 Is Required for the Secretion of EspBM
Cell lysates (CL) and culture filtrates (CF) were prepared from wild-type M. marinum strain 1218 and isogenic mutants as described in Materials and Methods. CL and CF proteins were separated by SDS-PAGE and the indicated proteins detected by western blot. Cultures of each strain were inoculated into Sauton's medium at an optical density (OD) of 0.5 and grown for 36 h. Therefore, the samples of each strain are normalized by OD readings. Of the total CL and CF fractions collected for each strain from one experiment, 3% of the CL was loaded in each lane and 15% of the total CF was loaded into each lane.
(1.0 MB TIF)
Figure S3. Mh3879c Is Not Secreted and the Carboxyterminus of Rv3879 Is Required for Interaction with EspB
Cell lysates (CL) and culture filtrates (CF) were prepared from the indicated strains as described in Materials and Methods. Proteins were separated by SDS-PAGE and the indicated proteins were detected by western blot strains as described in Materials and Methods.
(A) Cultures of each strain were inoculated into Sauton's medium at an OD of 0.5 and grown for 36 h. Therefore, the samples of each strain are normalized by OD readings. Of the total CL and CF fractions collected for each strain from one experiment, 3% of the CL was loaded in each lane and 15% of the total CF was loaded into each lane.
(B) Agarose beads with immobilized GST only, GST-Rv3871, or GST-EspBT were incubated with E. coli lysates that express V5-tagged Rv3879c full-length (1–729), Rv3879c Δ(1–166), or Rv3879c Δ(564–729). The input lysate (0.1%) and the material from the cell lysates that bound to the beads was run on SDS-PAGE and detected by western blotting with an antibody against V5.
(2.9 MB TIF)
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html) accession numbers for the gene products discussed in this paper are CFP-10 (NP_218391), ESAT-6 (YP_178023), Rv3866 (NP_218383), Rv3867 (NP_218384), Rv3868 (NP_218385), Rv3870 (NP_218387), Rv3871 (NP_218388), Rv3876 (NP_218393), Rv3877 (NP_218394), Rv3878 (NP_218395), Rv3879c (NP_218396), Rv3880c (NP_218397), and Rv3881c (NP_218398).
We thank Jun Liu (University of Toronto) for the M. marinum 1218 strains. We thank Colorado State University for providing us with materials as part of National Institutes of Health, National Institute of Allergy and Infectious Diseases Contract number HHSN266200400091C, entitled “Tuberculosis Vaccine Testing and Research Materials,” and Stephen Johnston and the Arizona State University CIM Antibody Core for providing us with the anti-EspB antibody. We thank Joanne Engel and members of the Brown and Cox laboratories for helpful comments throughout the course of this research. We also thank Joel Ernst for helpful comments on this manuscript.
BM and EJB conceived and designed the experiments and analyzed the data. BM, JSC, JAM, and TLC performed the experiments. BM, JAM, FC, JSC, and EJB contributed reagents/materials/analysis tools. BM, FC, JSC, and EJB wrote the paper.
- 1. Stanley SA, Raghavan S, Hwang WW, Cox JS (2003) Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A 100: 13001–13006.SA StanleyS. RaghavanWW HwangJS Cox2003Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system.Proc Natl Acad Sci U S A1001300113006
- 2. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, et al. (2003) The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A 100: 12420–12425.T. HsuSM Hingley-WilsonB. ChenM. ChenAZ Dai2003The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.Proc Natl Acad Sci U S A1001242012425
- 3. Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, et al. (2004) Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 51: 359–370.KM GuinnMJ HickeySK MathurKL ZakelJE Grotzke2004Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis.Mol Microbiol51359370
- 4. Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R (2004) ESAT-6 proteins: Protective antigens and virulence factors? Trends Microbiol 12: 500–508.P. BrodinI. RosenkrandsP. AndersenST ColeR. Brosch2004ESAT-6 proteins: Protective antigens and virulence factors?Trends Microbiol12500508
- 5. Gey Van Pittius NC, Gamieldien J, Hide W, Brown GD, Siezen RJ, et al. (2001) The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol 2: RESEARCH0044.NC Gey Van PittiusJ. GamieldienW. HideGD BrownRJ Siezen2001The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria.Genome Biol2RESEARCH0044
- 6. Macgurn JA, Cox JS (2007) A genetic screen for M. tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect Immun 75: 2668–7268.JA MacgurnJS Cox2007A genetic screen for M. tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system.Infect Immun7526687268
- 7. Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, et al. (2004) A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol Microbiol 53: 1677–1693.LY GaoS. GuoB. McLaughlinH. MorisakiJN Engel2004A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion.Mol Microbiol5316771693
- 8. Tan T, Lee WL, Alexander DC, Grinstein S, Liu J (2006) The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation. Cell Microbiol 8: 1417–1429.T. TanWL LeeDC AlexanderS. GrinsteinJ. Liu2006The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation.Cell Microbiol814171429
- 9. Volkman HE, Clay H, Beery D, Chang JC, Sherman DR, et al. (2004) Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol 2: e367.. HE VolkmanH. ClayD. BeeryJC ChangDR Sherman2004Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant.PLoS Biol2e367.
- 10. Flint JL, Kowalski JC, Karnati PK, Derbyshire KM (2004) The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis. Proc Natl Acad Sci U S A 101: 12598–12603.JL FlintJC KowalskiPK KarnatiKM Derbyshire2004The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis.Proc Natl Acad Sci U S A1011259812603
- 11. Converse SE, Cox JS (2005) A protein secretion pathway critical for Mycobacterium tuberculosis virulence is conserved and functional in Mycobacterium smegmatis. J Bacteriol 187: 1238–1245.SE ConverseJS Cox2005A protein secretion pathway critical for Mycobacterium tuberculosis virulence is conserved and functional in Mycobacterium smegmatis.J Bacteriol18712381245
- 12. Stinear TP, Seemann T, Pidot S, Frigui W, Reysset G, et al. (2007) Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res 17: 192–200.TP StinearT. SeemannS. PidotW. FriguiG. Reysset2007Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer.Genome Res17192200
- 13. Yip MJ, Porter JL, Fyfe JA, Lavender CJ, Portaels F, et al. (2007) Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J Bacteriol 189: 2021–2029.MJ YipJL PorterJA FyfeCJ LavenderF. Portaels2007Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor.J Bacteriol18920212029
- 14. Fortune SM, Jaeger A, Sarracino DA, Chase MR, Sassetti CM, et al. (2005) Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A 102: 10676–10681.SM FortuneA. JaegerDA SarracinoMR ChaseCM Sassetti2005Mutually dependent secretion of proteins required for mycobacterial virulence.Proc Natl Acad Sci U S A1021067610681
- 15. Champion PA, Stanley SA, Champion MM, Brown EJ, Cox JS (2006) C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science 313: 1632–1636.PA ChampionSA StanleyMM ChampionEJ BrownJS Cox2006C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis.Science31316321636
- 16. Okkels LM, Andersen P (2004) Protein-protein interactions of proteins from the ESAT-6 family of Mycobacterium tuberculosis. J Bacteriol 186: 2487–2491.LM OkkelsP. Andersen2004Protein-protein interactions of proteins from the ESAT-6 family of Mycobacterium tuberculosis.J Bacteriol18624872491
- 17. Okkels LM, Muller EC, Schmid M, Rosenkrands I, Kaufmann SH, et al. (2004) CFP10 discriminates between nonacetylated and acetylated ESAT-6 of Mycobacterium tuberculosis by differential interaction. Proteomics 4: 2954–2960.LM OkkelsEC MullerM. SchmidI. RosenkrandsSH Kaufmann2004CFP10 discriminates between nonacetylated and acetylated ESAT-6 of Mycobacterium tuberculosis by differential interaction.Proteomics429542960
- 18. Renshaw PS, Lightbody KL, Veverka V, Muskett FW, Kelly G, et al. (2005) Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 24: 2491–2498.PS RenshawKL LightbodyV. VeverkaFW MuskettG. Kelly2005Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6.EMBO J2424912498
- 19. MacGurn JA, Raghavan S, Stanley SA, Cox JS (2005) A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis. Mol Microbiol 57: 1653–1663.JA MacGurnS. RaghavanSA StanleyJS Cox2005A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis.Mol Microbiol5716531663
- 20. Collins DM, Skou B, White S, Bassett S, Collins L, et al. (2005) Generation of attenuated Mycobacterium bovis strains by signature-tagged mutagenesis for discovery of novel vaccine candidates. Infect Immun 73: 2379–2386.DM CollinsB. SkouS. WhiteS. BassettL. Collins2005Generation of attenuated Mycobacterium bovis strains by signature-tagged mutagenesis for discovery of novel vaccine candidates.Infect Immun7323792386
- 21. Mattow J, Schaible UE, Schmidt F, Hagens K, Siejak F, et al. (2003) Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 24: 3405–3420.J. MattowUE SchaibleF. SchmidtK. HagensF. Siejak2003Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen.Electrophoresis2434053420
- 22. Ratliff TL, McCarthy R, Telle WB, Brown EJ (1993) Purification of a mycobacterial adhesin for fibronectin. Infect Immun 61: 1889–1894.TL RatliffR. McCarthyWB TelleEJ Brown1993Purification of a mycobacterial adhesin for fibronectin.Infect Immun6118891894
- 23. Baulard AR, Gurcha SS, Engohang-Ndong J, Gouffi K, Locht C, et al. (2003) In vivo interaction between the polyprenol phosphate mannose synthase Ppm1 and the integral membrane protein Ppm2 from Mycobacterium smegmatis revealed by a bacterial two-hybrid system. J Biol Chem 278: 2242–2248.AR BaulardSS GurchaJ. Engohang-NdongK. GouffiC. Locht2003In vivo interaction between the polyprenol phosphate mannose synthase Ppm1 and the integral membrane protein Ppm2 from Mycobacterium smegmatis revealed by a bacterial two-hybrid system.J Biol Chem27822422248
- 24. Gao LY, Groger R, Cox JS, Beverley SM, Lawson EH, et al. (2003) Transposon mutagenesis of Mycobacterium marinum identifies a locus linking pigmentation and intracellular survival. Infect Immun 71: 922–929.LY GaoR. GrogerJS CoxSM BeverleyEH Lawson2003Transposon mutagenesis of Mycobacterium marinum identifies a locus linking pigmentation and intracellular survival.Infect Immun71922929
- 25. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST (2002) Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46: 709–717.AS PymP. BrodinR. BroschM. HuerreST Cole2002Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.Mol Microbiol46709717
- 26. Takeshita S, Kaji K, Kudo A (2000) Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15: 1477–1488.S. TakeshitaK. KajiA. Kudo2000Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.J Bone Miner Res1514771488
- 27. Wu AL, Wang J, Zheleznyak A, Brown EJ (1999) Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol Cell 4: 619–625.AL WuJ. WangA. ZheleznyakEJ Brown1999Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane.Mol Cell4619625
- 28. N'Diaye EN, Brown EJ (2003) The ubiquitin-related protein PLIC-1 regulates heterotrimeric G protein function through association with Gbetagamma. J Cell Biol 163: 1157–1165.EN N'DiayeEJ Brown2003The ubiquitin-related protein PLIC-1 regulates heterotrimeric G protein function through association with Gbetagamma.J Cell Biol16311571165
- 29. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, et al. (1991) New use of BCG for recombinant vaccines. Nature 351: 456–460.CK StoverVF de la CruzTR FuerstJE BurleinLA Benson1991New use of BCG for recombinant vaccines.Nature351456460